Heska Corp
HSKADelisted Jun 13, 2023- Industry
- In Vitro & In Vivo Diagnostic Substances
- SEC CIK
- 0001038133
Heska Corp was delisted on Jun 13, 2023; its insiders filed their last Form 4 on Jun 14, 2023; 152 institutions reported holding it in 13F filings for Q1 2023, worth $1.01B in total; no superinvestor held it.
Q4 2021 vs. Q3 2021
How the institutions holding Heska Corp changed between Q3 2021 and Q4 2021.
All holders in Q4 2021All holders in Q3 2021
| Measure | Q3 2021 | Of which not filed for Q4 2021 | Q4 2021 | Change |
|---|---|---|---|---|
| Holders | 195 | 1 | 185 | −9 |
| Shares | 10.1M | 1 | 10.4M | +235.5K (+2.3%) |
| Value | $2.62B | $0 | $1.89B | −$728.5M (−27.8%) |
1 institution that held it in Q3 2021 haven't filed for Q4 2021 yet. Not filing isn't selling, so the changes leave them out.
New holders (27)
Institutions that held Heska Corp at the end of Q4 2021 but not at the end of Q3 2021.
Sold out (36)
Institutions that held Heska Corp at the end of Q3 2021 and filed for Q4 2021 without it.
Not filed for Q4 2021 yet (1)
Institutions that held Heska Corp at the end of Q3 2021 and haven't filed a 13F for Q4 2021. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q3 2021 | Value, Q3 2021 |
|---|---|---|
| Berman Capital Advisors, LLC | 1 | $0 |